Congenital long QT syndrome with compound mutations in the KCNH2 gene.
about
A high-risk patient with long-QT syndrome with no response to cardioselective beta-blockers.Secondly ECG recordings in the emergency room revealed Garenoxacin-induced abnormal QT interval prolongation in a patient with multiple syncopal attacks.Adrenal insufficiency causes life-threatening arrhythmia with prolongation of QT interval.
P2860
Congenital long QT syndrome with compound mutations in the KCNH2 gene.
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Congenital long QT syndrome with compound mutations in the KCNH2 gene.
@ast
Congenital long QT syndrome with compound mutations in the KCNH2 gene.
@en
type
label
Congenital long QT syndrome with compound mutations in the KCNH2 gene.
@ast
Congenital long QT syndrome with compound mutations in the KCNH2 gene.
@en
prefLabel
Congenital long QT syndrome with compound mutations in the KCNH2 gene.
@ast
Congenital long QT syndrome with compound mutations in the KCNH2 gene.
@en
P2093
P2860
P1433
P1476
Congenital long QT syndrome with compound mutations in the KCNH2 gene
@en
P2093
Koji Yamaguchi
Masashi Akaike
Masataka Sata
Sachiko Bando
Takashi Iwase
Takayuki Ise
Takeshi Aiba
Takeshi Soeki
Tetsuzo Wakatsuki
Tomomi Matsuura
P2860
P2888
P304
P356
10.1007/S00380-013-0406-2
P577
2013-09-22T00:00:00Z
P6179
1052387883